Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
healthcare data - search results
If you're not happy with the results, please do another search
Pfizer vaccine can be given to 12-15 year olds in US
On Wednesday (12 May), the CDC announced that the Pfizer vaccine could now be given to 12-15 year olds - effective immediately for 17 million adolescents.
Research reveals five reasons behind UK vaccine hesitancy
New data explores why some in the UK continue to experience vaccine hesitancy - with one man explaining that "it is human nature to have second thoughts".
One in five UK adults experienced depression during lockdown
According to new ONS data, one in five adults experienced some form of depression during lockdown - more than double the pre-pandemic rate.
Drinking tea & coffee reduces risk of death in type-2 diabetes by 63%
A new study has found that drinking 4 cups of green tea or 2 cups of coffee per day reduces the risk of death in type-2 diabetes by 63%.
Turning the national illness service into the national health service
Robin Stern, Chair at Future Perfect (Healthcare), discusses how patient journeys currently reflect a national 'illness' service, not a national health service.
Brazilian COVID mutation more likely to evade immunity
The city of Manaus was hit so overwhelmingly by the Brazilian COVID mutation, it was believed that 75% of the population had COVID - what new truths are scientists learning about this powerful variant?
What are the side effects of the Pfizer vaccine?
Here, we assess some of the most common side effects of the Pfizer and BioNTech COVID-19 vaccine.
Cybersecurity threats to the COVID-19 vaccine
Raymond Pompon, Director of F5 Labs, looks at the cybersecurity threats to the COVID-19 vaccine amid the rise in cyber attacks since the onset of the pandemic.
EU to create new contract with Pfizer for 1.8 billion doses
Yesterday (14 April) EU President Ursula von der Leyen announced that the Commission would create a third contract with Pfizer, for 1.8 billion doses between 2021 to 2023.
New UK study will mix Moderna and Novavax COVID doses
Researchers in the UK started a clinical trial on mixing vaccines in February - today (14 April) a new study will look into mixing Moderna and Novavax doses.
US stops Johnson & Johnson vaccine to investigate blood clot risk
US authorities paused the use of the Johnson & Johnson single dose vaccine as they look into six cases of blood clots that developed in women aged between 18 and 48.
After COVID, can we better manage and prevent the likely rise in elderly falls?
Barak Katz, VP and GM Essence SmartCare, discusses the future of fall prevention and establishing more proactive elderly care, post COVID-19.
Why does the U.S. need an STI National Strategic Plan?
Open Access Government discusses STI prevention in the U.S., and the benefits and priorities of the STI National Strategic Plan 2021-2025.
Healthy under-30s should take alternative vaccine to AstraZeneca
The UK's medical authorities cleared continued use of AstraZeneca, but say that 18-29 year olds should take an alternative vaccine to AstraZeneca if possible.
Improving cancer treatment and services during and beyond COVID-19
Greg Quinn, BD UK, explores how cancer treatment and services have been impacted by the pandemic and the potential role of medical technology in supporting the NHS during this complex time.
HealthTracker™ for patients, clinician & researchers
Professor Paramala Santosh, CEO of HealthTracker Ltd, co-developed the HealthTrackerTM platform – developed by clinicians, assisted by patients for patients, clinicians & researchers, more of which we learn about here.
Biosimilars: Improve access to treatment & reduce cost
Tore K Kvien & Guro L Goll argue that biosimilars are an opportunity for improving access to treatment & reducing cost and provide comment on the NOR-SWITCH study.
Creating a healthier post-coronavirus culture
Sue Johnson Gregory, principal consultant, and Tim Powlson, senior business consultant at Entec Si, explain how to build a stronger, more joined up workforce in the face of future healthcare crises.
Zebra Technologies: Dedicated to improving global health
We spoke with Tony Cecchin, Vice President and General Manager of Global Supplies at Zebra Technologies and President of Temptime Corporation, and Chris Caulfield, Vice President of Temptime Operations about their work supporting front-line workers and easing the shipment of medical products through the supply chain.
Africa: Strengthening public health surveillance systems
Several seasoned academic experts describe the move towards strengthening public health surveillance systems in Africa.
